The Krebs cycle, also known as the citric acid cycle or the tricarboxylic acid cycle (TCA cycle), describes the metabolic pathways of the higher-order plants and animals in which available fuels, oxygen, water, and other essentials to life are utilized in an aerobic mode. The metabolic system is a well-documented and familiar process involving the basic steps to produce a “higher” form of life. The protection provided by at least 32 steps in the process provides a system that protects the oxygen-driven plants and animals.
Lower-order organisms are not near as complex in their metabolic pathways as higher-order organisms such as a tree or a human. The cycle followed by organisms such as bacteria and fungi, as well as certain diseased cells in higher-order life forms, follow a less complicated process that allows the disease to multiply at an almost exponential rate in an anaerobic cycle that has far fewer steps. The unique metabolic cycle of cancer cells and their ravenous appetite was first observed by Warburg. The disease utilizes all available minerals, sugars, fats, and proteins to fuel the reproduction of cells using the abbreviated anaerobic cycle. The higher the rate of replication, the less oxygen is available for healthy tissues surrounding the disease. Reduced oxygen aids in the fermentation process that is part of the favorable conditions required for the exponential growth of cells and organisms employing the anaerobic cycle, including infections and abnormal cells.
The CC Formula exploits a flaw in the exponential expansion mechanism of the disease organism. Specifically, it exploits the mineral-gathering mechanism of the organism against itself. Lower orders of disease organisms gather the necessary minerals and other building blocks in an amount proportional to their availability in the environment. This differs from the metabolic processes of higher organisms that only gather enough of the elements and building blocks to satisfy the requirements of the Krebs cycle.
Higher organisms will only incorporate minerals and other nutrients at a rate necessary for survival, while lower organisms and certain diseased cells will accumulate minerals in an amount that is toxic. Therefore, providing a high concentration of ionic minerals to a disease area could result in a toxic level of the mineral to disease organisms and allow survival of higher organisms so long as the dosage rate of the ionic minerals is below the toxic level for the higher organism.
The CC Formula uses highly bio-available ionic minerals at a rate that will kill the lower organism without impairing the function of the higher organism. This formulation transports all the minerals systemically to a plant, animal, or human with assistance of an artificial superoxide dismutase (SOD) carrier. The artificial SOD carrier causes the disease-causing cell or organism to uptake an amount of ionic mineral that is toxic which results in death of the disease cell or organism. Additionally, many diseases follow an anaerobic fermentation process which oxygen will impair thereby suggesting a secondary mechanism for destroying the disease. The CC Formula also contains sulfur which may further aid in destroying disease and relief of pain. However, the prime mode of action is the uptake of minerals in a highly biologically available formulation.
The general principle of the CC Formula is rapid entry into the aerobic biological system of a plant or animal using a mineral complex carrier in an ionic form which penetrates and migrates toward an anaerobic disease system if present. The product is capable of penetrating the barrier zone between the aerobic and anaerobic tissues if the disease is internal. Other mineral formulations are not as bioavailable, being unable to pass through cellular tissues as easily as the CC Formula. The unique quality of the formulation is thus its penetration of the membrane and the movement of large amounts of ionic minerals into the disease area.
Diseases have three vulnerable sites that can be attacked by treatment:
1. Penetrating the outer membrane of the disease,
2. Destroying the internal components that drive the cells metabolism, and
3. Destroying the gene pool that may provide a future defense (resistance) against the introduced substance.
Minerals that are not in the bioavailable form will not be able to eliminate or otherwise disable the disease cells because the minerals cannot pass through the membrane coating the outer surface of the disease cells and/or cannot travel in an extracellular fashion. The bioavailable minerals will attack all of the vulnerable targets in the disease cells because of the systemic capabilities of the formulation. When using the bioavailable formulation, the cell membrane should be easily transversed and possibly ruptured, the inner cell compromised because of the Krebs cycle (aerobic vs. anaerobic) as described above, and the genetic code of the disease cell destroyed by apoptosis. There should be no further deviations from the genetic code to produce new strains that may be resistant to the CC Formula. In fact, there are no known resistances to plant and/or animal disease when the primary source of the product being used is a mineral.